Vitamin D

Ultrahuman Revolutionizes Home Health with the Launch of Ultrahuman Home

Retrieved on: 
Tuesday, January 9, 2024

The pioneer in wearable tech unveils a ground-breaking Ultrahuman Home device at CES 2024

Key Points: 
  • Unveiled at CES 2024 in January, Ultrahuman Home introduces a new capability for individuals to track and enhance the health of their living spaces.
  • Personalizing or changing these markers' basis recommendations from the Ultrahuman home platform is expected to help improve the passive factors that affect an individual's health.
  • Ultrahuman Home will help individuals to track and enhance the health of their living spaces.
  • This on-body and off-body health tracking integration is the first time ever in the health monitoring space," said Mohit Kumar, Founder and CEO of Ultrahuman.

Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for distribution and commercialisation of three endocrinology therapies in Australia and select South-East Asia countries

Retrieved on: 
Sunday, January 7, 2024

Under the terms of the agreement, ST will commercialise Ascendis Pharma's weekly injectable paediatric human growth hormone treatment SKYTROFATM (lonapegsomatropin), hypoparathyroidism treatment YORVIPATHTM (palopegteriparatide) and investigational achondroplasia therapy TransCon™ CNP (navepegritide).

Key Points: 
  • Under the terms of the agreement, ST will commercialise Ascendis Pharma's weekly injectable paediatric human growth hormone treatment SKYTROFATM (lonapegsomatropin), hypoparathyroidism treatment YORVIPATHTM (palopegteriparatide) and investigational achondroplasia therapy TransCon™ CNP (navepegritide).
  • The agreement spans ST's key regions of Australia, New Zealand, Singapore, Malaysia, Brunei, Thailand, and Vietnam.
  • Announcing the partnership, ST Chief Executive Officer Carlo Montagner said this agreement was an important company milestone, signalling ST's expansion into both endocrinology and paediatric medicine.
  • "We are delighted to partner with Specialised Therapeutics to broaden the reach of our endocrinology rare disease portfolio, contributing to our shared goal of making a meaningful difference for patients facing unmet medical needs," she said.

Healthy Extracts Launches First Anti-Aging Formulation, LONGEVITY

Retrieved on: 
Thursday, January 4, 2024

In celebration of the launch, for a limited time you can buy two and get one free .

Key Points: 
  • In celebration of the launch, for a limited time you can buy two and get one free .
  • “LONGEVITY Anti-Aging complements our growing heart health product portfolio which supports a holistic approach to anti-aging like healthy skin,” noted Healthy Extracts president, Duke Pitts.
  • LONGEVITY Anti-Aging is your ally for overall longevity, blending ingredients renowned for their anti-aging benefits that support a longer, healthier life.
  • To learn more about Healthy Extracts’ full line of clinically-backed, natural brain and hearth health products, go to bergametna.com or tryubn.com .

Improving Immunity This Cold and Flu Season

Retrieved on: 
Wednesday, January 3, 2024

FORT LAUDERDALE, Fla., Jan. 3, 2024 /PRNewswire/ -- Every year, U.S. citizens suffer from over a billion colds. The CDC also estimates that they come down with between 9.4 and 41 million cases of the flu annually in recent years. This leads to hundreds of thousands of hospitalizations and thousands of deaths. Whether it is an unfortunate inconvenience or a life-threatening concern, every American is aware of the dangers of cold and flu season.

Key Points: 
  • The CDC also estimates that they come down with between 9.4 and 41 million cases of the flu annually in recent years.
  • Whether it is an unfortunate inconvenience or a life-threatening concern, every American is aware of the dangers of cold and flu season.
  • While it's possible to treat cold and flu symptoms after contracting an illness, the best solution is to take preventative measures.
  • "Our Immunity Boost gummies are particularly helpful during cold and flu season.

A Decade of Defining Moments

Retrieved on: 
Tuesday, January 2, 2024

With the theme of "Cultivating Change: A Decade of Defining Moments for People and the Planet," the conference will commence with a stellar 10th Anniversary Celebration, marking a major milestone in the organization's journey.

Key Points: 
  • With the theme of "Cultivating Change: A Decade of Defining Moments for People and the Planet," the conference will commence with a stellar 10th Anniversary Celebration, marking a major milestone in the organization's journey.
  • "In commemorating a decade of defining moments, we are looking forward to reflecting and celebrating what we have achieved through our vitamin D consumer awareness initiatives and our advocacy for transparency and consumer choice, particularly on platforms like Amazon," said Karen Howard , CEO and executive director of O&N Health.
  • The Organic & Natural Health Association is a necessity in this sector, and has left an indelible mark.
  • We are on fire, we are here to stay, and we will continue to shape and influence the cosmic landscape of our industry."

Human medicines European public assessment report (EPAR): Eladynos, abaloparatide, Date of authorisation: 12/12/2022, Revision: 3, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024

Human medicines European public assessment report (EPAR): Eladynos, abaloparatide, Date of authorisation: 12/12/2022, Revision: 3, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Eladynos, abaloparatide, Date of authorisation: 12/12/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Date of authorisation: 15/04/2005, Revision: 32, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Date of authorisation: 15/04/2005, Revision: 32, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Date of authorisation: 15/04/2005, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 17, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 17, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 17, Status: Authorised

Tenth Study Demonstrates Good Health in Vegan Dogs

Retrieved on: 
Thursday, November 9, 2023

And now a study just published in the British Journal of Nutrition has demonstrated good health outcomes in dogs fed vegan diets.

Key Points: 
  • And now a study just published in the British Journal of Nutrition has demonstrated good health outcomes in dogs fed vegan diets.
  • Dr Sarah Dodd and other veterinary nutritional specialists from Canada's Ontario Veterinary College found that 31 dogs fed vegan diets for three months had health outcomes as good as 30 fed meat-based diets.
  • This is the latest among 10 studies that have now confirmed good health outcomes in dogs fed vegan diets.
  • In 2002 Prof. Knight and colleagues also studied health outcomes in 2,536 dogs and concluded that the healthiest and least hazardous diets for dogs were nutritionally sound vegan diets.

How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way

Retrieved on: 
Wednesday, November 22, 2023

Most medical experts agree we are in a global mental health crisis and it is only worsening.

Key Points: 
  • Most medical experts agree we are in a global mental health crisis and it is only worsening.
  • While some companies turn to traditional methods including pharmaceuticals to solve the growing problem, others are looking to revolutionize the way we treat mental health using technology, and AI is aiming to take the driver's seat.
  • Also using technology for mental health, Talkspace, a leading virtual behavioral healthcare company recently reported third quarter 2023 financial results.
  • As PanGenomic Health says – AI and other technology may become natural health's 'smart tech partner' of the future.